Safety and Efficacy of the Vascular Closure Device (Tonbridge) in Hemostasis Treatment of Femoral Artery Puncture

NACompletedINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

May 22, 2023

Primary Completion Date

January 27, 2024

Study Completion Date

March 1, 2024

Conditions
Vascular ClosureEndovascular ProcedureHemostasisFemoral ArteryPuncture
Interventions
DEVICE

Vascular Closure Device (Tonbridge)

Hemostasis treatment for femoral artery puncture with Vascular Closure Device (Tonbridge).

DEVICE

EXOSEAL Vascular Closure Device (Codis Corporation)

Hemostasis treatment for femoral artery puncture with EXOSEAL Vascular Closure Device (Codis Corporation).

Trial Locations (7)

Unknown

The First Affiliated Hospital of Wannan Medical College, Wuhu

Nanyang Central Hospital, Nanyang

Puyang Oilfield General Hospital, Puyang

Henan Provincial People's Hospital, Zhengzhou

The Second Affiliated Hospital of Soochow University, Suzhou

General Hospital of Northern Theater Command, Shenyang

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

Ton-Bridge Medical Tech. Co., Ltd

INDUSTRY

NCT05822804 - Safety and Efficacy of the Vascular Closure Device (Tonbridge) in Hemostasis Treatment of Femoral Artery Puncture | Biotech Hunter | Biotech Hunter